radiograph
examin
fluid
test
blood
urin
sputum
stool
possibl
tissu
biopsi
radiograph
abnorm
abund
densiti
chemic
microenviron
tissu
allow
distinct
surround
normal
tissu
tradit
absorpt
electromagnet
wave
tissu
led
summat
differ
exposur
silver
salt
photograph
film
tomograph
approach
ct
nmr
complement
summat
radiolog
allow
fine
detail
visual
intern
anatomi
plane
section
era
ultrasound
allow
visual
tissu
densiti
differ
develop
fetu
gallbladd
stone
recent
physiolog
neoplasm
screen
positron
emiss
tomographi
pet
decay
short
halflif
isotop
fluorodeoxyglucos
neoplasm
high
metabol
distinguish
physiolog
adjac
lowmetabol
tissu
local
respect
normal
tissu
pair
pet
standard
ct
result
astonishingli
use
mean
identifi
local
new
spaceoccupi
mass
assign
risk
malign
behavior
malign
screen
metastas
distant
site
techniqu
revolution
preoper
decisionmak
clinic
team
improv
likelihood
patient
undergo
resect
new
mass
lesion
risk
morbid
malign
behavior
interfer
normal
function
patholog
diseas
diagnos
determin
whether
morpholog
featur
match
set
diagnost
criteria
previous
describ
diseas
multivolum
text
devot
gross
microscop
diagnost
criteria
use
diagnosi
prognosi
predict
respons
therapi
pathologist
diagnos
diseas
gener
differenti
diagnosi
find
best
fit
clinic
present
radiograph
appear
patholog
clinic
lab
morpholog
find
logic
venn
diagram
clinic
radiolog
patholog
differenti
diagnos
overlap
unexpect
featur
expand
differenti
diagnosi
may
rais
possibl
previous
undescrib
diseas
exampl
legionnair
diseas
human
immunodefici
viru
hiv
hantaviru
pneumonia
sever
acut
respiratori
syndrom
sar
exampl
newli
describ
diagnos
last
year
mental
construct
etiolog
caus
pathogenesi
progress
natur
histori
clinic
outcom
respons
therapi
standard
approach
pathologist
think
diseas
diseas
may
one
etiolog
initi
caus
includ
toxin
mutagen
drug
allergen
trauma
genet
mutat
diseas
expect
follow
particular
seri
event
develop
pathogenesi
follow
particular
clinic
cours
natur
histori
diseas
result
temporari
last
chang
normal
function
includ
patient
death
multipl
diseas
differ
etiolog
affect
singl
organ
exampl
infecti
neoplast
diseas
involv
lung
differ
diseas
deriv
singl
etiolog
exampl
emphysema
chronic
bronchiti
small
cell
lung
carcinoma
longterm
smoker
diseas
instanc
emphysema
lung
deriv
differ
etiolog
emphysema
defici
cigarett
smoke
modern
diagnost
patholog
practic
hing
morpholog
diagnosi
supplement
histochem
stain
immunohistochem
stain
cytogenet
clinic
laboratori
find
well
clinic
radiograph
find
section
meet
criteria
diagnost
diseas
criteria
present
make
definit
diagnosi
pathologist
must
either
equivoc
make
altern
diagnosi
thu
firm
grasp
diagnost
criteria
instinct
rapidli
creat
sort
differenti
diagnosi
must
possess
diagnost
pathologist
patholog
diagnosi
make
sens
morpholog
perspect
clinic
radiograph
vantag
point
well
legal
riski
profession
eros
make
clinic
patholog
imposs
diagnosi
recent
past
limit
comput
network
meant
numer
phone
call
gather
relev
clinic
radiograph
inform
make
inform
morpholog
diagnosi
exampl
certain
diseas
squamou
small
cell
carcinoma
lung
extrem
rare
nonsmok
thu
small
cell
carcinoma
lung
nonsmok
merit
screen
nonpulmonari
primari
site
fortun
pathologist
comput
network
technolog
allow
us
access
preoper
clinic
workup
radiographsreport
clinic
laboratori
data
prior
patholog
report
data
protect
pathologist
provid
relev
clinic
radiograph
inform
protect
patient
improv
diagnost
accuraci
research
scientist
ignor
literatur
peril
diagnost
pathologist
ignor
present
past
histori
workup
prior
biopsi
radiograph
peril
limit
morpholog
diagnosi
h
e
stain
first
lineag
certain
class
neoplasm
includ
small
round
blue
cell
tumor
clear
cell
neoplasm
spindl
cell
neoplasm
undifferenti
malign
neoplasm
usual
clarifi
immunohistochemistri
frequent
cytogenet
perform
sometim
electron
microscopi
second
limit
inher
snapshot
biopsi
resect
thu
etiolog
pathogenesi
obscur
indetermin
rate
growth
invas
time
metastasi
infer
third
morpholog
chang
may
specif
underli
molecular
abnorm
particularli
ratelimit
therapeut
target
step
pathogenesi
neoplasm
exampl
ret
gain
function
mutat
medullari
thyroid
carcinoma
requir
dna
level
screen
determin
germlin
involv
famili
risk
presenc
absenc
therapeut
target
fourth
morpholog
appear
may
ident
two
differ
diseas
would
treat
differ
exampl
morpholog
evid
h
e
stain
alon
distinguish
host
lymphoid
respons
hepat
c
viral
hcv
antigen
host
lymphoid
respons
allohla
antigen
liver
allograft
obvious
major
diagnost
challeng
transplant
done
hcvrelat
cirrhosi
probabl
recurr
hcv
infect
liver
allograft
high
paraffin
section
immunohistochemistri
proven
invalu
neoplasm
diagnosi
clarifi
lineag
improv
diagnost
accuraci
guid
custom
therapi
neoplasm
poorli
differenti
undifferenti
lineag
neoplasm
may
clear
exampl
sheet
undifferenti
malign
neoplasm
promin
nucleoli
could
repres
carcinoma
lymphoma
melanoma
clarifi
lineag
panel
immunostain
perform
protein
express
neoplasm
other
rel
probabl
use
lend
support
rule
exclud
rule
particular
diagnos
differenti
diagnosi
sever
morpholog
similar
undifferenti
neoplasm
second
role
make
critic
distinct
diagnosi
accur
made
h
e
alon
exampl
would
includ
demonstr
myoepitheli
cell
loss
invas
breast
carcinoma
mimic
scleros
adenosi
figur
loss
basal
cell
invas
prostat
carcinoma
figur
third
role
immunohistochemistri
identifi
particular
protein
nuclear
estrogen
receptor
er
figur
plasma
membran
protein
figur
target
inhibitor
rather
gener
system
chemotherapi
morpholog
remain
gold
standard
diagnost
process
immunohistochem
data
support
fail
support
h
e
find
vice
versa
probabl
statist
regular
consider
immunohistochem
interpret
sinc
antigen
tissuespecif
lineagespecif
cytokeratin
posit
carcinoma
also
synovi
epithelioid
sarcoma
exampl
may
impli
aspect
lineag
two
sarcoma
may
help
categor
neoplasm
anoth
exampl
would
diagnosi
small
cell
carcinoma
lung
nonsmok
lung
primari
small
cell
carcinoma
extrem
uncommon
nonsmok
diagnosi
would
prompt
pathologist
inquir
screen
result
nonpulmonari
primari
site
likewis
immunohistochemistri
result
alway
put
context
morpholog
clinic
radiograph
find
exampl
undifferenti
neoplasm
testi
support
embryon
carcinoma
primari
testi
wherea
lymph
node
effac
sclerot
band
admix
reedsternberg
cell
support
nodular
scleros
hodgkin
diseas
wealth
inform
convey
servic
pathologist
triedandtru
h
e
section
analog
fact
plain
chest
xray
sum
total
densiti
beam
path
morpholog
chang
diseas
cell
tissu
morpholog
sum
total
disequilibria
abnorm
cell
neoplast
diseas
morpholog
criteria
suffici
predict
risk
invas
metastasi
malign
potenti
pattern
metastas
like
clinic
outcom
exampl
etiolog
pathogenesi
small
cell
lung
carcinoma
infer
cigarett
smoke
carcinogeninduc
genet
mutat
outcom
predict
earli
metastasi
region
node
distant
organ
high
probabl
death
within
year
diagnosi
new
molecular
data
neoplast
nonneoplast
diseas
like
benefit
unaffect
individu
estim
diseas
risk
like
benefit
patient
defin
molecular
subset
morpholog
defin
diagnost
entiti
thu
guid
individu
therapi
diagnost
patholog
continu
use
morpholog
complementari
data
protein
immunohistochem
nucleic
acid
cytogenet
situ
hybrid
dna
sequenc
rna
abund
screen
assay
new
data
integr
diagnost
process
reduc
cost
turnaround
time
current
technolog
develop
new
technolog
describ
transplant
candid
major
histocompat
complex
mhc
hla
human
screen
evolv
cellular
assay
serolog
toward
sequenc
allel
class
ii
hla
loci
rapid
sequenc
allel
newborn
cord
blood
would
allow
databas
popul
haplotyp
facilit
perfect
match
requir
bone
marrow
solid
organ
transplant
current
use
situ
hybrid
screen
virus
ebv
light
chain
restrict
b
lymphoma
copi
number
variat
instanc
gene
amplif
demonstr
benefit
situ
nucleic
acid
hybrid
assay
possibl
interphas
fishcish
becom
rapid
enough
use
initi
diagnost
workup
certain
patient
includ
sarcomaspecif
transloc
ploidi
analysi
hydatidiform
mole
gene
amplif
receptor
tyrosin
kinas
gene
current
use
nucleic
acid
screen
bcrabl
transloc
donor
recipi
ratio
bone
marrow
transplant
microsatellit
instabl
quantit
viral
load
ebv
bk
cmv
other
singl
gene
mutat
cftr
factor
demonstr
benefit
nucleic
acid
screen
diagnosi
manag
possibl
new
neoplasm
promptli
defin
ploidi
transloc
gene
copi
number
differ
dna
mutat
rna
express
cluster
subset
allow
residu
diseas
screen
well
individu
therapi
current
use
morpholog
immunohistochemistri
molecular
patholog
demonstr
benefit
improv
diagnost
accuraci
howev
diagnosi
extent
diseas
molecular
subset
current
imperfect
estim
prognosi
respons
therapi
relat
databas
correl
individu
demograph
data
famili
histori
concurr
diseas
morpholog
featur
immunophenotyp
molecular
subset
integr
diseas
preval
age
sex
ethnic
use
bayesian
probabl
improv
accuraci
prognosi
predict
respons
therapi
risk
correl
develop
possibl
healthi
individu
screen
given
risk
estim
develop
differ
diseas
current
use
normal
rang
serum
chemistri
assum
similar
bellcurv
distribut
across
age
sex
race
may
true
analyt
comput
refer
databas
like
gener
normal
rang
specif
particular
agesexethn
individu
patient
similarli
famili
risk
inherit
diseas
may
vari
ethnic
group
variat
use
bayesian
calcul
defin
risk
unaffect
atrisk
famili
member
current
use
liver
renal
impair
guid
drug
dosag
demonstr
benefit
use
patient
physiolog
custom
therapi
like
individu
differ
enzymat
metabol
particular
drug
instanc
warfarin
tamoxifen
defin
enzym
sequenc
level
gene
haplotyp
data
determin
new
patient
prior
receipt
drug
current
use
prostatespecif
antigen
psa
screen
prostat
carcinoma
recurr
demonstr
benefit
serum
biomark
common
neoplasm
like
highsensit
screen
singl
cluster
serum
analyt
lead
improv
method
earli
detect
persist
neoplasm
autoimmun
diseas
infect
pathologist
consid
diseas
natur
mechan
physicochem
basi
diseas
etiolog
initi
caus
pathogenesi
stepwis
progress
natur
histori
effect
normal
function
clinic
outcom
pathologist
collect
data
need
answer
patient
clinician
question
simpli
phrase
diagnosi
go
behav
prognosi
treat
predict
respons
therapi
instinct
diagnost
criteria
well
optic
mechan
chemic
comput
technolog
describ
previous
basi
modern
servic
patholog
human
genom
deciph
complex
interact
cellular
biochemistri
refin
risk
diseas
unaffect
individu
calcul
diseas
diagnosi
increasingli
accur
prognost
molecular
subset
morpholog
defin
diseas
entiti
use
guid
custom
therapi
individu
patient
great
time
histori
pathologist
n
clinic
diseas
present
frontlin
physician
patient
set
sign
symptom
symptom
patient
complaint
perceiv
abnorm
sign
detect
examin
patient
clinic
team
includ
pathologist
evalu
patient
base
possibl
caus
sign
symptom
differenti
diagnosi
n
patholog
diseas
diagnos
determin
whether
morpholog
featur
match
set
diagnost
criteria
previous
describ
diseas
pathologist
diagnos
diseas
gener
differenti
diagnosi
find
best
fit
clinic
present
radiograph
appear
patholog
clinic
lab
morpholog
find
n
etiolog
describ
caus
diseas
one
diseas
entiti
one
etiolog
singl
etiolog
lead
one
diseas
exampl
emphysema
chronic
bronchiti
small
cell
lung
carcinoma
occur
longterm
smoker
differ
diseas
deriv
singl
etiolog
likewis
diseas
instanc
emphysema
lung
deriv
differ
etiolog
emphysema
defici
cigarett
smoke
n
pathogenesi
diseas
describ
stepwis
progress
initi
respons
specif
etiolog
factor
factor
pathogenesi
refer
chang
structur
function
organ
grossclin
level
refer
stepwis
molecular
abnorm
lead
chang
cellular
tissu
function
n
natur
histori
diseas
describ
expect
cours
diseas
includ
chronic
function
impair
surviv
howev
patient
given
diseas
natur
follow
diseas
cours
differ
patient
outcom
necessarili
correspond
incorrect
diagnosi
variabl
independ
correl
clinic
outcom
differ
call
independ
prognost
variabl
assess
routin
effort
predict
natur
histori
diseas
patient
n
likewis
variabl
independ
correl
respons
therapi
call
independ
predict
variabl
assess
routin
effort
optim
therapeut
respons
patient
